Clascoterone cream 1% plus adapalene gel 0.3% offers an effective, well-tolerated topical option for moderate to severe acne, ...

The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...

Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. In a clinical trial, scientists are investigating whether a vaccine could treat patients with ...

Acne sufferers may benefit from following a Mediterranean diet and taking omega-3 fatty acid supplements derived from algae, a new study out of Germany finds. The research, published Wednesday in the ...

USA: Researchers have found in a new study that Clindamycin phosphate 1.2% / adapalene 0.15% / benzoyl peroxide 3.1% (CAB) ...

Acne remains a very common inflammatory dermatosis, which is often associated with significant psychological morbidity. It frequently affects young adults at a time when they are undergoing maximal ...

Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

Medically reviewed by Casey Gallagher, MD Neck acne happens when oil, sweat, dead skin cells, or products clog your ...